ClinicalTrials.gov
public full text
Public Domain
Reduced Intensity Transplant in Medically Refractory Systemic Lupus Erythematosus (SLE) and Systemic Sclerosis (SSc)
The purpose of this study is to determine if a reduced intensity (RI) (non-myeloablative) chemoimmunotherapy followed by Allogeneic Stem Cell Transplantation AlloSCT (matched family donors and matched unrelated cord blood donors) will be well tolerated.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A symposium update on the key perspectives in systemic sclerosis and systemic lupus erythematosus#448828
- Vaccination in systemic lupus erythematosus#205415
- Ejercicios físicos supervisados en el hogar en una paciente con lupus eritematoso sistémico Lima – Perú, 2022-2023#211937
- Impact of Pre-existing Invasive Aspergillosis on Allogeneic Stem Cell Transplantation#1103980
- A Study of MT-0551 in Patients With Systemic Sclerosis#1095268
Record · ID 894696
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive